|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss显示文摘 | Marcucci R Alessandrello LA Cellai AP | 2005 | Thromb Haemost2005，3，5： | 1 |
| 2 | Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss 显示文摘 | MARCUCCI R ALESSANDRELLO LIOT'I'A A CELLAI AP | 2005 | J Thromb Haemost2005，3，5： | 1 |
| 3 | Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss显示文摘 | Marcucci R Alessandrello L A Cellai A P | 2005 | Thromb Haemost2005，3，： | 1 |
| 4 | Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss显示文摘 | Marcucci R Alessandrello LA Cellai AP | 2005 | J Thromb Haemost2005，3，5： | 1 |
| 5 | Cardiovascular and thrombophilic risk factors for idiopathic sudden sens orineural hearing loss显示文摘 | Marcucci R Alessandrello LA Cellai AP | 2005 | Thromb Haemost2005，3，： | 1 |
| 6 | Reduced erythrocyte deformability and hypercoagulability in idiopathic sudden sensorineural hearing loss显示文摘 | Lucia Mannini Rita Paniccia Emanuele Cecchi Agatina Alessandrello Liotta Emanuela Leprini Pasquale Berloco Paolo Pagnini Rosanna Abbate Gian Franco Gensini Domenico Prisco | 2005 | Clinical Hemorheology and Microcirculation2005，，： | 1 |
| 7 | Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing 10ss显示文摘 | Marcucci R Alessandrello Liotta A Cellai AP | 2005 | J Thromb Haemost2005，3，5： | 1 |
| 8 | Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss显示文摘 | Marcucci R Alessandrello LA Cellai AP | 2005 | J Thromh Haemost2005，3，5： | 1 |
| 9 | Electrophysiologic procedures and activation of the hemostatic system显示文摘 | Antonio Michelucci Emilia Antonucci Andrea A. Conti Agatina Alessandrello Liotta Sandra Fedi Luigi Padeletti Maria Cristina Porciani Domenico Prisco Rosanna Abbate Gian Franco Gensini | 1999 | American Heart Journal1999，，1： | 1 |
| 10 | New experimental results on double beta decay of 130Te显示文摘 | Brofferio C Cremonsi O | 2000 | Phys Lett B2000，486，12： | 1 |
| 11 | Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss显示文摘 | Marcucci R Alessandrello LA Cellai AP | 2005 | J Thromb Haemost2005，3，5： | 1 |
| 12 | D-dimer plasma levels during nomml pregnancy measured by specific ELISA 显示文摘 | Francalanei I Comeglio P Alessandrello Liotta A | 1997 | Int J Clin Lab Res1997，27，1： | 1 |
| 13 | High-resolution Bolometers for Rare Events Detection显示文摘 | Vanzini M Alessandrello A Brofferio C | 2001 | Nuclear Instruments and Methods in Physics Research A2001，461，： | 1 |
| 14 | Assessment of platelet function: Laboratory and point-of-care methods显示文摘In the event of blood vessel damage, human platelets are promptly recruited on the site of injury and, after their adhesion, activation and aggregation, prevent blood loss with the formation of a clot. The consequence of abnormal regulation can be either hemorrhage or the development of thrombosis. Qualitative and/or quantitative defects in platelets promote bleeding, whereas the residual reactivity of platelets, despite antiplatelet therapies, play an important role in promoting arterial thrombotic complications. Platelet function is traditionally assessed to investigate the origin of a bleeding syndrome, to predict the risk of bleeding prior surgery or during pregnancy or to monitor the efficacy of antiplatelet therapy in thrombotic syndromes that, now, can be considered a new discipline. 'Old' platelet function laboratory tests such as the evaluation of bleeding time and the platelet aggregation analysis inplatelet-rich plasma are traditionally utilized to aid in the diagnosis and management of patients with platelet and hemostatic disorders and used as diagnostic tools both in bleeding and thrombotic diathesis in specialized laboratories. Now, new and renewed automated systems have been introduced to provide a simple, rapid assessment of platelet function including point of care methods. These new methodologies are also suitable for being used in non-specialized laboratories and in critical area for assessing platelet function in whole blood without the requirement of sample processing. Some of these methods are also beginning to be incorporated into routine clinical use and can be utilized as not only as first panel for the diagnosis of platelet dysfunction, but also for monitoring anti-platelet therapy and to potentially assess risk of both bleeding and/or thrombosis. | Rita Paniccia Raffaella Priora Agatina Alessandrello Liotta Niccolò Maggini Rosanna Abbate | 2014 | World Journal of Translational Medicine2014，3，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员